Amdocs price target raised to $97 from $85 at Baird

Baird analyst William Power raised the firm’s price target on Amdocs to $97 from $85 and keeps a Neutral rating on the shares. The firm said the company reported solid FQ1 results, including in-line revenue and adjusted EPS and the company also maintained prior full year revenue, EPS and free cash flow guidance.